Fingerprint
Dive into the research topics of 'RAD51 Foci as a Biomarker Predictive of Platinum Chemotherapy Response in Ovarian Cancer'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
RAD51 Foci as a Biomarker Predictive of Platinum Chemotherapy Response in Ovarian Cancer
Amanda J. Compadre, Lillian N. van Biljon, Mark C. Valentine, Alba Llop-Guevara, Emily Graham, Bisiayo Fashemi, Andrea Herencia-Ropero, Emilee N. Kotnik, Isaac Cooper, Shariska P. Harrington, Lindsay M. Kuroki, Carolyn K. McCourt, Andrea R. Hagemann, Premal H. Thaker, David G. Mutch, Matthew A. Powell, Lulu Sun, Nima Mosammaparast, Violeta Serra, Peinan Zhao
- Division of Gynecologic Oncology
- Institute for Public Health
- Institute of Clinical and Translational Sciences (ICTS)
- Siteman Cancer Center
- Department of Obstetrics & Gynecology
- Division of Anatomic and Molecular Pathology (AMP)
- Division of Laboratory and Genomic Medicine
- Roy and Diana Vagelos Division of Biology & Biomedical Sciences (DBBS)
- DBBS - Biochemistry, Biophysics, and Structural Biology
- DBBS - Cancer Biology
- DBBS - Molecular Cell Biology
- DBBS - Molecular Genetics and Genomics
- Division of Clinical Research
- Washington University School of Medicine
- Intellectual and Developmental Disabilities Research Center (IDDRC)
- Bursky Center for Human Immunology & Immunotherapy Programs (CHiiPs)
Research output: Contribution to journal › Article › peer-review
27
Scopus
citations